U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06899165) titled 'Psilocybin-Assisted Therapy for Intergenerational Trauma' on March 21.
Brief Summary: This is an open-label psilocybin-assisted therapy study that will examine the safety and tolerability of psilocybin-assisted therapy in the offspring of genocide survivors with mood and anxiety disorders.
The study will also investigate the efficacy of psilocybin-assisted therapy in reducing symptoms such as depression, anxiety and stress, as well as changes to the psychological effects of parental exposure to genocide, and changes to psychological resilience.
Study Start Date: June 01, 2025
Study Type: INTERVENTIONAL
Condition:
Psychological...